Suppr超能文献

钙依赖转酰胺酶活性在组织转谷氨酰胺酶对阿霉素诱导凋亡的保护作用中的重要性

Importance of Ca(2+)-dependent transamidation activity in the protection afforded by tissue transglutaminase against doxorubicin-induced apoptosis.

作者信息

Datta Sunando, Antonyak Marc A, Cerione Richard A

机构信息

Department of Chemistry and Chemical Biology, Cornell University, Ithaca, New York 14853, USA.

出版信息

Biochemistry. 2006 Nov 7;45(44):13163-74. doi: 10.1021/bi0606795.

Abstract

Tissue transglutaminase II (TGase-II), which is capable of both GTP binding and transamidation activities, has been implicated in a variety of biological disorders ranging from cancer to neurodegenerative diseases. Recent studies have suggested that the transamidation activity of TGase-II is necessary for the survival of cancer cells confronted with different stresses and cellular insults. When assayed in vitro, the transamidation activity of TGase-II is Ca(2+)-dependent. However, at present, little is known with regard to how the regulation by Ca(2+) is manifested or if in fact it is important for the cellular functions of TGase-II. Here, we have set out to further examine the Ca(2+)-mediated regulation of TGase-II's transamidation activity, with our goals being to identify the Ca(2+)-regulatory sites on the protein and determine whether they are essential for TGase-II to confer survival to human breast cancer cells. On the basis of comparisons between the X-ray crystal structures of TGase-II and TGase-III, we identified three putative Ca(2+)-regulatory sites on TGase-II. Site-directed mutagenesis was performed to individually alter key residues at each of the sites. These substitutions did not affect the ability of TGase-II to bind guanine nucleotides, nor did they cause any obvious changes in its cellular localization. While substitutions at the different Ca(2+)-regulatory sites could either slightly enhance or markedly reduce the GTP hydrolytic activity of TGase-II, mutations at each of the three sites inhibited the Ca(2+)-responsive transamidation activity. We further showed that the same substitutions inhibited the ability of TGase-II to protect human breast cancer cells against the apoptotic activity of doxorubicin. Overall, these findings demonstrate that the Ca(2+)-mediated regulation of transamidation activity is essential for the ability of TGase-II to confer cell survival.

摘要

组织转谷氨酰胺酶II(TGase-II)具有GTP结合活性和转酰胺基活性,与从癌症到神经退行性疾病等多种生物学紊乱有关。最近的研究表明,TGase-II的转酰胺基活性对于面临不同应激和细胞损伤的癌细胞存活是必需的。在体外测定时,TGase-II的转酰胺基活性是Ca(2+)依赖性的。然而,目前对于Ca(2+)的调节如何表现,或者它实际上对TGase-II的细胞功能是否重要知之甚少。在这里,我们着手进一步研究Ca(2+)介导的对TGase-II转酰胺基活性的调节,目标是确定该蛋白上的Ca(2+)调节位点,并确定它们对于TGase-II赋予人乳腺癌细胞存活能力是否至关重要。基于TGase-II和TGase-III的X射线晶体结构比较,我们在TGase-II上确定了三个假定的Ca(2+)调节位点。进行了定点诱变以分别改变每个位点的关键残基。这些取代不影响TGase-II结合鸟嘌呤核苷酸的能力,也未引起其细胞定位的任何明显变化。虽然在不同Ca(2+)调节位点的取代可轻微增强或显著降低TGase-II的GTP水解活性,但三个位点中的每个位点的突变均抑制了Ca(2+)反应性转酰胺基活性。我们进一步表明,相同的取代抑制了TGase-II保护人乳腺癌细胞免受阿霉素凋亡活性影响的能力。总体而言,这些发现表明Ca(2+)介导的对转酰胺基活性的调节对于TGase-II赋予细胞存活的能力至关重要。

相似文献

2
GTP-binding-defective forms of tissue transglutaminase trigger cell death.
Biochemistry. 2007 Dec 25;46(51):14819-29. doi: 10.1021/bi701422h. Epub 2007 Dec 1.
4
GTP is required to stabilize and display transamidation activity of transglutaminase 2.
Biochem Biophys Res Commun. 2002 Jun 21;294(4):818-22. doi: 10.1016/S0006-291X(02)00582-X.
5
The core domain of the tissue transglutaminase Gh hydrolyzes GTP and ATP.
Biochemistry. 1997 Sep 30;36(39):11655-64. doi: 10.1021/bi970545e.
6
Effects of tissue transglutaminase on retinoic acid-induced cellular differentiation and protection against apoptosis.
J Biol Chem. 2001 Sep 7;276(36):33582-7. doi: 10.1074/jbc.M105318200. Epub 2001 Jul 3.
7
Tissue transglutaminase protects against apoptosis by modifying the tumor suppressor protein p110 Rb.
J Biol Chem. 2002 Jun 7;277(23):20127-30. doi: 10.1074/jbc.C200147200. Epub 2002 Apr 15.
9
Phospholipase C, Ca2+, and calmodulin signaling are required for 5-HT2A receptor-mediated transamidation of Rac1 by transglutaminase.
Psychopharmacology (Berl). 2011 Feb;213(2-3):403-12. doi: 10.1007/s00213-010-1984-7. Epub 2010 Aug 18.
10
Two isoforms of tissue transglutaminase mediate opposing cellular fates.
Proc Natl Acad Sci U S A. 2006 Dec 5;103(49):18609-14. doi: 10.1073/pnas.0604844103. Epub 2006 Nov 20.

引用本文的文献

2
4
The diamond anniversary of tissue transglutaminase: a protein of many talents.
Drug Discov Today. 2018 Mar;23(3):575-591. doi: 10.1016/j.drudis.2018.01.037. Epub 2018 Jan 31.
6
Strategies towards in vivo imaging of active transglutaminase type 2 using positron emission tomography.
Amino Acids. 2017 Mar;49(3):585-595. doi: 10.1007/s00726-016-2288-y. Epub 2016 Jul 5.
7
The Different Conformational States of Tissue Transglutaminase Have Opposing Affects on Cell Viability.
J Biol Chem. 2016 Apr 22;291(17):9119-32. doi: 10.1074/jbc.M115.699108. Epub 2016 Feb 18.
8
Methylglyoxal in cells elicits a negative feedback loop entailing transglutaminase 2 and glyoxalase 1.
Redox Biol. 2014 Jan 10;2:196-205. doi: 10.1016/j.redox.2013.12.024. eCollection 2014.
9
A mechanism for the upregulation of EGF receptor levels in glioblastomas.
Cell Rep. 2013 Jun 27;3(6):2008-20. doi: 10.1016/j.celrep.2013.05.021. Epub 2013 Jun 13.
10
Structural characterization of a conserved, calcium-dependent periplasmic protease from Legionella pneumophila.
J Bacteriol. 2012 Aug;194(16):4415-25. doi: 10.1128/JB.00640-12. Epub 2012 Jun 15.

本文引用的文献

2
Cystamine treatment is neuroprotective in the YAC128 mouse model of Huntington disease.
J Neurochem. 2005 Oct;95(1):210-20. doi: 10.1111/j.1471-4159.2005.03357.x.
3
Tissue transglutaminase 2 inhibition promotes cell death and chemosensitivity in glioblastomas.
Mol Cancer Ther. 2005 Sep;4(9):1293-302. doi: 10.1158/1535-7163.MCT-04-0328.
4
Chemistry and biology of dihydroisoxazole derivatives: selective inhibitors of human transglutaminase 2.
Chem Biol. 2005 Apr;12(4):469-75. doi: 10.1016/j.chembiol.2005.02.007.
5
Tissue transglutaminase inhibition.
Chem Biol. 2005 Apr;12(4):410-2. doi: 10.1016/j.chembiol.2005.04.001.
8
Transglutaminases: crosslinking enzymes with pleiotropic functions.
Nat Rev Mol Cell Biol. 2003 Feb;4(2):140-56. doi: 10.1038/nrm1014.
9
Cystamine inhibits caspase activity. Implications for the treatment of polyglutamine disorders.
J Biol Chem. 2003 Feb 7;278(6):3825-30. doi: 10.1074/jbc.M205812200. Epub 2002 Nov 27.
10
Tissue transglutaminase differentially modulates apoptosis in a stimuli-dependent manner.
J Neurochem. 2002 May;81(4):780-91. doi: 10.1046/j.1471-4159.2002.00859.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验